GlucoseReady Whitepaper
Clinical Ink Logo

GlucoseReady™: Diabetes

Delivers CGM/BGM, eCOA and Behavioral management
for diabetes trials

GlucoseReady™:
Weight Management/NASH

eCOA + Behavioral management for obesity trials
Full 1
Clinical Ink Logo

WEBINAR ON DEMAND

How Patient-Centered Technologies Can Elevate Diabetes Clinical Trials to Align with Current Standards of Care

Our panel of clinical experts addresses the recent FDA guidance on continuous glucose monitoring (CGM).
Full 1
Clinical Ink Logo

Reduce your Study Build Timeline to 10 Days

Innovative eCOA technology sets new standard for speed, efficiency, and accuracy in study build process. Read the press release.
Full 1
Clinical Ink Logo

Nature Magazine Publishes Work Demonstrating Clinical ink Technology Sensitivity to Parkinson’s Disease

Full 1
Clinical Ink Logo

COA vs. eCOA Cost Calculator

Get your study-specific cost comparison between paper COA and eCOA within 48 hours. See how much you can save today.
Full 1
Clinical Ink Logo

Breakthrough Evidence with Digital Biomarkers in Movement Disorders

See how we successfully demonstrated disease status and treatment response for clinical development and medical practice.

Clinical ink is leading the way to recenter decentralized clinical trials by connecting data and operations.

At the core of our clinical trial solutions is the Clinical ink eSource ecosystem, designed to ingest all incoming data into a unified data platform that supports analytics within and across studies, regardless of how it was captured or by whom.

A Better eSource Solution

Clinical ink’s eSource methods integrate Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA) for a wide range of phases and therapeutic areas.

The result is faster, higher-quality clinical trial data. Our eSource solutions ingest data from multiple sources, facilitating decentralized trials and shifting the industry towards capturing data directly from the patient.

eSource ecosystem by Clinical ink

Lorem Ipsum sit Amet Dolor

Clinical ink’s eSource methods integrate Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA) for a wide range of phases and therapeutic areas.

The result is faster, higher-quality clinical trial data. Our eSource solutions ingest data from multiple sources, facilitating decentralized trials and shifting the industry towards capturing data directly from the patient.

0 +
Studies
0 +
Assessments
and Instruments
0 +
BYOD Studies
1 M+
Cognitive and Behavioral Measures
0 +
Sponsors and CROs

eSource Technology

See everything our eSource technology platform has to offer.

eSource technologies improve the efficiency and reduce the cost of clinical trials, particularly in the context of complex therapeutic areas. 

The depth and breadth of our therapeutic experience – across neurology, infectious disease, immunology, and oncology – means you get the expertise and improved results for your clinical research. 

Neurology

Improve results for complex clinical trials involving central nervous system conditions.

Infectious Disease

Speed up trial timelines and improve the data quality of your infectious disease studies.

Immunology

Leverage eSource tools to simplify and improve outcomes in complex Lupus clinical trials.

Oncology

Deliver on the Enhancing Oncology Model and improve patient adherence throughout the trial.

Diabetes

Offer a better patient experience and improve trial outcomes for diabetes research.

Immunology

Leverage eSource tools to simplify and improve outcomes in complex Lupus clinical trials.

Infectious Disease

Speed up trial timelines and improve the data quality of your infectious disease studies.

Neurology

Improve results for complex clinical trials involving central nervous system conditions.

Neurology

Improve results for complex clinical trials involving central nervous system conditions.

Oncology

Deliver on the Enhancing Oncology Model and improve patient adherence throughout the trial.

Featured Insights and Resources

Scroll to Top

Download the GlucoseReady™ White Paper

Download the GlucoseReady™ white paper and see how our platform can streamline data capture, improve retention, and ensure regulatory compliance.

Contact Clinical ink

Request more information, submit questions, set up a demonstration, and more.